Opsoclonus: Difference between revisions
No edit summary |
No edit summary |
||
| Line 29: | Line 29: | ||
==External Links== | ==External Links== | ||
[http://www.nejm.org/doi/full/10.1056/NEJMicm1002035 NEJM Opsoclonus ] | *[http://www.nejm.org/doi/full/10.1056/NEJMicm1002035 NEJM Opsoclonus ] | ||
==References== | ==References== | ||
Latest revision as of 23:40, 17 November 2021
Background
- Definition: involuntary, irregular multidirectional saccadic eye movements.[1]
- Occurs at fixed gaze and has been reported with various medication overdoses such as organophosphates, lithium, cetirizine, amitryptiline, and diphenhydramine.[2]
Clinical Features
- Multidirectional involuntary eye movements when at fixed gaze
Differential Diagnosis
Neurologic Causes
Toxicologic
- Alcohol intoxication
- Amphetamines
- Barbiturates
- Benzodiazepines
- Ketamine
- Lithium toxicity
- Other anticonvulsants or sedatives
- Phencyclidine (PCP)
- Phenytoin (Dilantin)
- Salicylates
- SSRI toxicity
- Thiamine deficiency
Evaluation
Evaluation for symptoms of vertigo, CVA, and due to the association with medication overdoses, a psychiatric screening is worth consideration
- Glucose check
- Full neuro exam
- TM exam
- CTA or MRA (diagnostic study of choice) of the neck/brain if symptoms consistent with central cause
Management
- Supportive care and treatment focused on the underlying cause of the opsoclonus
Disposition
Generally patients are admitted if the etiology is due to an overdose and further supportive care and psychiatric monitoring is required.